| Safety, Tolerability, PK and PD of Posiphen® in Subjects With Early Alzheimer's Disease (NCT02925650) | Annovis Bio Inc. | 2017-03-02 |
| A Phase 1 TP-271 Oral PK Single Ascending Dose Study (NCT03024034) | Tetraphase Pharmaceuticals, Inc | 2017-03-02 |
| Trial of Mistletoe Extract in Patients With Advanced Solid Tumors (NCT03051477) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-03-01 |
| Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer (NCT03101579) | The First Hospital of Jilin University | 2017-03-01 |
| A Clinical Study of CD19 Targeted CAR-T for Patients With CD19+ Lymphoma and Leukemia (NCT03383952) | Immune Cell, Inc. | 2017-03-01 |
| Sequential Infusion of Anti-CD19 and Anti-CD20 CAR-T Cells Against Relapsed and Refractory B-cell Lymphoma (NCT03207178) | Shanghai Longyao Biotechnology Inc., Ltd. | 2017-03-01 |
| Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers (NCT03072485) | Anne Chang | 2017-03-01 |
| The Effect of Inhaled Corticosteroids on Vocal Fold Nodules in Children (NCT03040596) | Joseph Dohar, MD | 2017-03-01 |
| Pre-operative RT and TMZ in Patients With Newly Diagnosed GBM Diagnosed Glioblastoma. A Phase I Study. (PARADIGMA) (NCT03480867) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2017-03-01 |
| The Effect of Acute Lysine Administration on α-aminoadipic Acid (Sub-study) (NCT03063476) | Vanderbilt University Medical Center | 2017-03-01 |
| ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants (NCT04387539) | Beni-Suef University | 2017-03-01 |
| Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults (NCT02797171) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-03-01 |
| A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib (NCT03076164) | Memorial Sloan Kettering Cancer Center | 2017-03-01 |
| Phase II Study of TAK228 in Relapsed Lymphoma (NCT02727777) | M.D. Anderson Cancer Center | 2017-03-01 |
| A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE) (NCT03030976) | Shanghai GeneChem Co., Ltd. | 2017-03-01 |
| tTF-NGR Phase I Study (NCT02902237) | University Hospital Muenster | 2017-03-01 |
| Autologous Bronchial Basal Cells Transplantation for Treatment of Chronic Obstructive Pulmonary Disease (COPD) (NCT03092648) | Nanfang Hospital, Southern Medical University | 2017-03-01 |
| A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma (NCT02978235) | Taiho Oncology, Inc. | 2017-03-01 |
| The Effect of Intravenous L-kynurenine (LKYN) on Cerebral Hemodynamics in Healthy Volunteers (NCT03212430) | Danish Headache Center | 2017-03-01 |
| Safety and Pharmacokinetics of Oral F901318 (Fluconazole and Posaconazole) IN Aml Leukaemia (NCT03036046) | F2G Ltd | 2017-03-01 |
| Ruxolitinib Combined With Dexamethasone for HLH (NCT03795909) | Capital Research Institute of Pediatrics | 2017-03-01 |
| Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer (NCT02216669) | Maastricht Radiation Oncology | 2017-03-01 |
| New Approaches to Smoking Cessation in Heavy Drinkers (NCT02151591) | Yale University | 2017-03-01 |
| NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT03109158) | NanoCarrier Co., Ltd. | 2017-03-01 |
| Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease (NCT02937350) | University of Washington | 2017-03-01 |
| Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor (NCT03093688) | Shanghai Public Health Clinical Center | 2017-03-01 |
| Metoclopramide for Post-Traumatic Headache. A Pilot Study (NCT03056352) | Montefiore Medical Center | 2017-03-01 |
| Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma (NCT02956382) | Georgetown University | 2017-03-01 |
| Safety, Efficacy and Pharmacokinetic of BPI-9016M in Patients With c-Met- Dysregulated Advanced NSCLC (NCT02929290) | Betta Pharmaceuticals Co., Ltd. | 2017-03-01 |
| Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients (NCT03781895) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2017-03-01 |
| CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia (NCT03064269) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2017-03-01 |
| Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients (NCT02912754) | Sunnybrook Health Sciences Centre | 2017-03-01 |
| A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease (NCT02923375) | Cynata Therapeutics Limited | 2017-03-01 |
| rTMS Over the Supplementary Motor Area for Treatment-resistant Obsessive-compulsive Disorder. (NCT03211221) | CNS Onlus | 2017-03-01 |
| DPP4 Inhibition & Beta Cell Function (NCT02683187) | David D'Alessio, M.D. | 2017-03-01 |
| CD30 Targeted CAR-T in Treating CD30-Expressing Lymphomas (NCT03383965) | Immune Cell, Inc. | 2017-03-01 |
| Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients (NCT04391985) | Beni-Suef University | 2017-03-01 |
| Safety and Pharmacokinetics of Smoked Cannabis in Healthy Patients (NCT04314804) | Tetra Bio-Pharma | 2017-03-01 |
| Absolute BA and OZ439 PK Effect of Different OZ439 Dose Volumes and Cobicistat Co-administration Study (NCT04069221) | Medicines for Malaria Venture | 2017-02-28 |
| Longjohn Amgen Study - Effect of Denosumab... (NCT02444585) | University of Southern California | 2017-02-28 |
| Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder (NCT02723838) | Oncolytics Biotech | 2017-02-28 |
| Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis (NCT03050151) | Regeneron Pharmaceuticals | 2017-02-28 |
| Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors (NCT03065062) | Dana-Farber Cancer Institute | 2017-02-28 |
| Intermittent Selumetinib for Uveal Melanoma (NCT02768766) | Shaheer A. Khan | 2017-02-28 |
| ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma (NCT03003637) | The Netherlands Cancer Institute | 2017-02-28 |
| Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors (NCT02808650) | Children's Oncology Group | 2017-02-27 |
| Effect of Probenecid on Pexidartinib Pharmacokinetics (NCT03138759) | Daiichi Sankyo | 2017-02-27 |
| Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206) (NCT02959437) | Incyte Corporation | 2017-02-27 |
| A Relative Bioavailability Study of Two Formulations of BCX7353 (NCT03202784) | BioCryst Pharmaceuticals | 2017-02-27 |
| Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults (NCT03605212) | Menarini Group | 2017-02-27 |
| Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin (NCT03063580) | Sanofi | 2017-02-27 |
| Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers (NCT02478463) | ViiV Healthcare | 2017-02-27 |
| Study in Subjects With Small Primary Choroidal Melanoma (NCT03052127) | Aura Biosciences | 2017-02-27 |
| Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC (NCT03085966) | Shanghai AbelZeta Ltd. | 2017-02-27 |
| A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects (NCT03086382) | UCB Biopharma S.P.R.L. | 2017-02-27 |
| A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol (NCT03203499) | Amygdala Neurosciences, Inc. | 2017-02-27 |
| BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma (NCT03070327) | Memorial Sloan Kettering Cancer Center | 2017-02-27 |
| Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas (NCT03030417) | National Cancer Institute (NCI) | 2017-02-27 |
| A Study of JHL1101 Versus MabThera® in Subjects With Severe Rheumatoid Arthritis (NCT03161457) | JHL Biotech, Inc. | 2017-02-27 |
| A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa (NCT03083704) | Portola Pharmaceuticals | 2017-02-26 |
| Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002) (NCT02762617) | Marla Keller | 2017-02-24 |
| Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients (NCT02969317) | Boehringer Ingelheim | 2017-02-24 |
| A Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy (NCT03084861) | Banc de Sang i Teixits | 2017-02-24 |
| Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer (NCT03094884) | Fox Chase Cancer Center | 2017-02-24 |
| PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects (NCT03069963) | Sanofi | 2017-02-24 |
| A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma (NCT02974725) | Novartis Pharmaceuticals | 2017-02-24 |
| Normothermic Liver Preservation Trial (NCT03089840) | University of Alberta | 2017-02-24 |
| Mesenchymal Stem Cells (MSCs) for Treatment of Acute Respiratory Distress Syndrome (ARD) in Patients With Malignancies (NCT02804945) | M.D. Anderson Cancer Center | 2017-02-24 |
| The Impact and Detection of Driving Impairments Associated With Acute Cannabis Smoking (NCT02849587) | University of California, San Diego | 2017-02-24 |
| A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors (NCT02952989) | Seagen Inc. | 2017-02-23 |
| A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump (NCT03056456) | Eli Lilly and Company | 2017-02-23 |
| A Study Of Changes In PD-L1 Expression During Preoperative Treatment With Nab-Paclitaxel And Pembrolizumab In Hormone Receptor-Positive Breast Cancer (NCT02999477) | Adrienne G. Waks | 2017-02-23 |
| Shigella WRSS1 Vaccine Trial in Bangladesh (NCT02934178) | PATH | 2017-02-23 |
| A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma (NCT02616965) | Fox Chase Cancer Center | 2017-02-22 |
| A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors (NCT03034304) | HRYZ Biotech Co. | 2017-02-22 |
| Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine (NCT02988739) | Pantec Biosolutions AG | 2017-02-22 |
| Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin (NCT03100006) | National Cancer Centre, Singapore | 2017-02-22 |
| A Study Evaluating MM-310 in Patients With Solid Tumors (NCT03076372) | Merrimack Pharmaceuticals | 2017-02-22 |
| Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults (NCT03049488) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-02-22 |
| A Phase Ib/II Study of Efficacy and Feasibility of Cytoreductive Surgery, Extensive Peritoneal Lavage, Hyperthermicintraperitoneal Chemotherapy and Post-operative Intraperitoneal Chemotherapy Combination in Gastric Cancer With Peritoneal Metastasis (NCT02995850) | Yonsei University | 2017-02-22 |
| Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Breast Cancer (NCT03083288) | Abramson Cancer Center at Penn Medicine | 2017-02-22 |
| Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer (NCT02910843) | Swiss Cancer Institute | 2017-02-22 |
| A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors (NCT02988960) | AbbVie | 2017-02-22 |
| Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT (NCT02962167) | Sabine Mueller, MD, PhD | 2017-02-22 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BP101 in Healthy Volunteers (NCT03102489) | Ivix LLX | 2017-02-22 |
| Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions (NCT03234699) | SK Life Science, Inc. | 2017-02-22 |
| Optimizing Treatment to Improve TBM Outcomes in Children (NCT02958709) | Johns Hopkins University | 2017-02-22 |
| A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma (NCT03075696) | Hoffmann-La Roche | 2017-02-21 |
| Bioavailability of AZD0284 and IV Microtracer Study (NCT03029741) | AstraZeneca | 2017-02-21 |
| Dose-finding Pharmacokinetic Study in Healthy Males (NCT03055936) | Orion Corporation, Orion Pharma | 2017-02-21 |
| An Open-Label Pharmacokinetics and Safety Study of Talazoparib (NCT02997163) | Pfizer | 2017-02-21 |
| VRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults (NCT03015181) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-02-21 |
| Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT02992522) | Beth Christian | 2017-02-21 |
| Safety Study of Live Attenuated Influenza Vaccine, CodaVax (NCT03926416) | Codagenix, Inc | 2017-02-21 |
| PK, PD, Tolerability and Safety of MDPK67b in Healthy Volunteers (NCT04839120) | Med Discovery SA | 2017-02-21 |
| Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma (NCT02898259) | Brian Hill | 2017-02-20 |
| A First-in-Human Study of PRL3-ZUMAB (NCT03191682) | National University Hospital, Singapore | 2017-02-20 |
| Avelumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia (NCT02953561) | M.D. Anderson Cancer Center | 2017-02-20 |
| Pembrolizumab and Paricalcitol With or Without Chemotherapy in Patients With Pancreatic Cancer That Can Be Removed by Surgery (NCT02930902) | M.D. Anderson Cancer Center | 2017-02-20 |
| Clinical Trial With MSC for Graft Versus Host Disease Treatment (NCT02687646) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2017-02-20 |